IL-33 expression was shown to be lower in the brains of Alzheimer's disease patients when compared to controls, and additional genetic investigation revealed three variants within the IL-33 gene, indicating a protective haplotype linked with Alzheimer's disease risk in non-APOE e4 carriers patients. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.